title: Stem cell therapy for diabetes.
abstract: Stem cell therapy holds immense promise for the treatment of patients with diabetes mellitus. Research on the ability of human embryonic stem cells to differentiate into islet cells has defined the developmental stages and transcription factors involved in this process. However, the clinical applications of human embryonic stem cells are limited by ethical concerns, as well as the potential for teratoma formation. As a consequence, alternative forms of stem cell therapies, such as induced pluripotent stem cells, umbilical cord stem cells and bone marrow-derived mesenchymal stem cells, have become an area of intense study. Recent advances in stem cell therapy may turn this into a realistic treatment for diabetes in the near future.
authors.affiliation: Department of Medicine, National University of Singapore, Singapore.
authors.forename: K O
authors.initials: KO
authors.lastname: Lee
authors.forename: S U
authors.initials: SU
authors.lastname: Gan
authors.forename: R Y
authors.initials: RY
authors.lastname: Calne
keywords: Embryonic stem cell; diabetes; induced pluripotent stem cell; mesenchymal stem cell
references.citation: Gene Ther. 2005 Apr;12(8):655-67
references.pmid: 15703765
references.citation: Cell Transplant. 2011;20(11-12):1827-41
references.pmid: 21439131
references.citation: PLoS One. 2008 Mar 05;3(3):e1734
references.pmid: 18320053
references.citation: Nat Rev Endocrinol. 2010 Mar;6(3):173-7
references.pmid: 20173779
references.citation: Cell. 2006 Aug 25;126(4):663-76
references.pmid: 16904174